Light, timing of biological rhythms, and chronodisruption in man

Naturwissenschaften

Volumn 90, Issue 11, 2003, Pages 485-494

  Erren, Thomas C ^a   Reiter, Russel J ^b   Piekarski, Claus ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

BIOLOGICAL RHYTHM; LIGHT;

AGING; BIOLOGICAL RHYTHM; CANCER; CHRONOBIOLOGY; ENVIRONMENTAL FACTOR; EVIDENCE BASED MEDICINE; LIGHT; PREMATURE AGING; REVIEW; SEASON; SOCIAL MEDICINE;

AGING; ANIMALS; BIOLOGICAL CLOCKS; CIRCADIAN RHYTHM; ENVIRONMENT; HUMANS; LIGHT; MELATONIN; NEOPLASMS; PERIODICITY;

EID: 0344944174     PISSN: 00281042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00114-003-0468-6     Document Type: Review

References (102)

1. Agrawal A, Chandra D, Kale RK (2001) Radiation induced oxidative stress. II. Studies in liver as a distant organ of tumor bearing mice. Mol Cell Biochem 224:9-17
2. Armstrong SM, Redman JR (1991) Melatonin: a chronobiotic with antiaging properties. Med Hypotheses 34:300-309
3. Auvinen A, Pukkala E, Blettner M (1999) Risk of breast cancer among female airline cabin attendants. Large European studies are now carried. BMJ 318:125-126
4. Ballard T, Lagorio S, De Angelis G, Verdecchia A (2000) Cancer incidence and mortality among flight personnel: a meta-analysis. Aviat Space Environ Med 71:216-224
5. Beck-Friis J, Rosen D von, Kjellman BF, Ljunggren JG, Wetterberg L (1984) Melatonin in relation to body measures, sex, age, season and the use of drugs in patients with major affective disorders and healthy subjects. Psychoneuroendocrinology 9:261-277
6. Bellingham J, Foster RG (2002) Opsins and mammalian photoentrainment. Cell Tiss Res 309:57-71
7. Berson DM, Dunn FA, Takao M (2002) Phototransduction by retinal ganglion cells that set the circadian clock. Science 295:1070-1073
8. Blackshaw S, Snyder SH (1999) Encephalopsin: a novel mammalian extraretinal opsin discretely localized in the brain. J Neurosci 19:3681-3690
9. Blask DE (1997) Systemic, cellular, and molecular aspects of melatonin action on experimental breast carcinogenesis. In: Stevens RG, Wilson BW, Anderson LE, (eds.) The melatonin hypothesis: breast cancer and the use of electric power. Battelle, Columbus, Ohio, pp 189-230
10. Blask DE (2001) An overview of the neuroendocrine regulation of experimental tumor growth by melatonin and its analogues and the therapeutic use of melatonin in oncology. In: Bartsch C, Bartsch H, Blask, DE, Cardinali DP, Hrushesky WJM, Mecke D (eds) The pineal gland and cancer. Springer, Berlin Heidelberg New York, pp 309-342
11. Blask DE, Sauer LA, Dauchy RT (2002a) Melatonin as a chronobiotic/ anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem 2:113-132
12. Blask DE, Dauchy RT, Sauer LA, Krause JA, Brainard GC (2002b) Light during darkness, melatonin suppression and cancer progression. Neuroendocrinol Lett 23(suppl 2):52-56
13. Boice JD Jr, Blettner M, Auvinen A (2000) Epidemiologic studies of pilots and aircrew. Health Phys 79:576-584
14. Brainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, Rollag MD (2001) Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci 21:6405-6412
15. Brzezinski A (1997) Melatonin in humans. N Engl J Med 336:186-195
16. Coleman MP, Reiter RJ (1992) Breast cancer, blindness and melatonin. Eur J Cancer 28:501-503
17. Czeisler CA, Shanahan TL, Klerman EB, Martens H, Brotman DJ, Emens JS, Klein T, Rizzo JF III (1995) Suppression of melatonin secretion in some blind patients by exposure to bright light. N Engl J Med 332:6-11
18. Darwin C (1859) On the ORIGIN OF SPECIES. Chapter IV: Natural selection; or the survival of the fittest
19. Dauchy RT, Sauer LA, Blask DE, Vaughan GM (1997) Light contamination during the dark phase in "photoperiodically controlled" animal rooms: effect on tumor growth and metabolism in rats. Lab Anim Sci 47:511-518
20. Davis S, Mirick DK, Stevens RG (2001) Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93:1557-1562
21. Erren TC (2001) A meta-analysis of epidemiologic studies of electric and magnetic fields and breast cancer in women and men. Bioelectromagnetics Suppl 5:S105-S119
22. Erren TC (2002) Does light cause internal cancers? The problem and challenge of an ubiquitous exposure. Neuroendocrinol Lett 23(suppl 2):61-70
23. Erren TC, Piekarski C (1999) Does winter darkness in the Arctic protect against cancer? The melatonin hypothesis revisited. Med Hypotheses 53:1-5
24. Erren TC, Bjerregaard P, Cocco P, Lerchl A, Verkasalo P (2001) Re:"Invited commentary: electromagnetic fields and cancer in railway workers. Am J Epidemiol 154:977-979
25. Feychting M, Osterlund B, Ahlbom A (1998) Reduced cancer incidence among the blind. Epidemiology 9:490-494
26. Freedman MS, Lucas RJ, Soni B, Schantz M von, Munoz M, David-Gray Z, Foster R (1999) Regulation of mammalian circadian behavior by non-rod, non-cone, ocular photoreceptors. Science 284:502-504
27. Gillette MU, Tischkau SA (1999) Suprachiasmatic nucleus: the brain's circadian clock. Rec Progr Harm Res 54:33-58
28. Glickman G, Levin R, Brainard GC (2002) Ocular input for human melatonin regulation: relevance to breast cancer. Neuroendocrinol Lett 23(suppl 2):17-22
29. Hahn RA (1991) Profound bilateral blindness and the incidence of breast cancer. Epidemiology 2:208-210
30. Halliwell B, Aruoma OI (1993) DNA and free radicals. Ellis Harwood, London
31. Hankins MW, Lucas RJ (2002) The primary visual pathway in humans is regulated according to long-term light exposure through the action of a nonclassical photopigment. Curr Biol 12:191-198
32. Hansen J (2001a) Increased breast cancer risk among women who work predominantly at night. Epidemiology 12:74-77
33. Hansen J (2001b) Light at night, shiftwork, and breast cancer risk. J Natl Cancer Inst 93:1513-1515
34. Härma M, Laitinen J, Partinen M, Suvanto S (1994) The effect of four-day round trip flights over 10 time zones on the circadian variation of salivary melatonin and cortisol in airline flight attendants. Ergonomics 37:1479-1489
35. Harman D (1992) Free radical theory of aging. Mutat Res 275:257-266
36. Hatonen T, Alila-Johansson A, Mustanoja S, Laakso ML (1999) Suppression of melatonin by 2000-lux light in humans with closed eyelids. Biol Psychiatry 46:827-831
37. Hattar S, Liao HW, Takao M, Berson DM, Yau KW (2002) Melanopsin- containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science 295:1065-1070
38. Hurd MW, Ralph MR (1998) The significance of circadian organization for longevity in the golden hamster. J Biol Rhythms 13:430-436
39. Jean-Louis G, Kripke DF, Cole RJ, Elliot JA (2000) No melatonin suppression by illumination of popliteal fossae or eyelids. J Biol Rhythms 15:265-269
40. Karbownik M, Reiter RJ (2000) Antioxidative effects of melatonin in protection against cellular damage by ionizing radiation. Proc Soc Exp Biol Med 225:9-22
41. Karbownik M, Lewinski A, Reiter RJ (2001) Anticarcinogenic actions of melatonin that involve antioxidative processes: comparison with other antioxidants. Int J Biochem Cell Biol 33:735-753
42. Kauppila A, Kivelä A, Pakarinen A, Vakkuri O (1987) Inverse seasonal relationship between melatonin and ovarian activity in humans in a region with strong seasonal contrast in luminosity. J Clin Endocrinol Metab 65:823-828
43. Kivelä A, Kauppila A, Ylostalo P, Vakkuri O, Leppaluoto J (1988) Seasonal, menstrual and circadian secretions of melatonin, gonadotropins and prolactin in women. Acta Physiol Scand 132:321-327
44. Klerman EB, Zeitzer JM, Duffy JF, Khalsa SB, Czeisler CA (2001) Absence of an increase in the duration of the circadian melatonin secretory episode in totally blind human subjects. J Clin Endocrinol Metab 86:3166-3170
45. Klerman EB, Shanahan TL, Brotman DJ, Rimmer DW, Emens JS, Rizzo JF III, Czeisler CA (2002) Photic resetting of the human circadian pacemaker in the absence of conscious vision. J Biol Rhythms 17:548-555
46. Kliukiene J, Tynes T, Andersen A (2001). Risk of breast cancer among Norwegian women with visual impairment. Br J Cancer 84:397-399
47. Laakso ML, Porkka-Heiskanen T, Alila A, Stenberg D, Johansson G (1994) Twenty-four-hour rhythms in relation to the natural photoperiod: a field study in humans. J Biol Rhythms 9:283-293
48. Levine ME, Milliron AN, Duffy LK (1994) Diurnal and seasonal rhythms of melatonin, cortisol and testosterone in interior Alaska. Arctic Med Res 53:25-34
49. Lockley SW, Skene DJ, Arendt J, Tabandeh H, Bird AC, Defrance R (1997) Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab 82:3763-3770
50. Lucas RJ, Freedman MS, Munoz M, Garcia-Fernandez JM, Foster RG (1999) Regulation of the mammalian pineal by non-rod, non-cone, ocular photoreceptors. Science 284:505-507
51. Lucas RJ, Douglas RH, Foster RG (2001) Characterization of an ocular photopigment capable of driving pupillary constriction in mice. Nat Neurosci 4:621-626
52. Lucas RJ, Hattar S, Takao M, Berson DM, Foster RG, Yau KW (2003) Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice. Science 299:245-247
53. Lynge E (2001) Commentary: cancer in the air. Int J Epidemiol 30:830-832
54. Martikainen H, Tapanainen J, Vakkuri O, Leppaluoto J, Huhtaniemi I (1985) Circannual concentrations of melatonin, gonadotrophins, prolactin and gonadal steroids in males in a geographical area with a large annual variation in daylight. Acta Endocrinol 109:446-450
55. Mawson AR (1998) Breast cancer in female flight attendants. Lancet 352:626
56. 2-based blue-light photoreceptors in the retinohypothalamic tract as the photoactive pigments for setting the circadian clock in mammals. Proc Natl Acad Sci USA 95:6097-6102
57. Panda S, Sato TK, Castrucci AM, Rollag MD, DeGrip WJ, Hogenesch JB, Provencio I, Kay SA (2002) Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting. Science 298:2213-2216
58. Panzer A, Viljoen M (1997) The validity of melatonin as an oncostatic agent. J Pineal Res 22:184-202
59. Poole C (2002) The darkness at the end of the tunnel: summary and evaluation of an international symposium on light, endocrine systems and cancer. Neuroendocrinol Lett 23(suppl 2):71-78
60. Portier CJ (2000) Decisions about environmental health risks: what are the key questions and how does this apply to melatonin? In: Erren TC, Piekarski C (eds) Low frequency EMF, visible light, melatonin and cancer: international symposium, 4-5 May 2000, University of Cologne. Zbl Arbeitsmed 2000 50:298-314. Available as summaries at http://www.uni-koeln.de/symposium2000/
61. Portier CJ (2002) Comments on the international symposium on light, endocrine systems and cancer. Neuroendocrinol Lett 23(suppl 2):79-81
62. Provencio I, Cooper HM, Foster RG (1998) Retinal projections in mice with inherited retinal degeneration: implications for circadian photoentrainment. J Comp Neurol 395:411-439
63. Provencio I, Rodriguez IR, Jiang G, Hayes WP, Moreira EF, Rollag MD (2000) A novel human opsin in the inner retina. J Neurosci 20:600-605
64. Provencio I, Rollag MD, Castrucci AM (2002) Photoreceptive net in the mammalian retina: this mesh of cells may explain how some blind mice can still tell day from night. Nature 415:493
65. Pukkala E, Verkasalo PK, Ojarno M, Rudanko S-L (1999) Visual impairment and cancer: a population-based cohort study in Finland. Cancer Causes Control 10:13-20
66. Pukkala E, Aspholm R, Auvinen A, Eliasch H, Gundestrup M, Haldorsen T, Hammar N, Hrafnkelsson J, Kyyronen P, Linnersjo A, Rafnsson V, Storm H, Tveten U (2002) Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study. BMJ 325:567-571
67. Reiter RJ (1991) Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 79:C153-158
68. Reiter RJ (1993) The melatonin rhythm: both a clock and a calendar. Experientia 49:654-664
69. Reiter RJ (1999) Oxidative damage to nuclear DNA: amelioration by melatonin. Neuroendocrinol Lett 20:145-150
70. Reiter RJ (2002) Potential biological consequences of excessive light exposure: melatonin suppression, DNA damage, cancer and neurodegenerative diseases. Neuroendocrinol Lett 23(suppl 2):9-13
71. Reiter RJ, Tan DX, Mayo JC, Sainz RM, Lopez-Burillo S (2002) Melatonin, longevity and health in the aged: an assessment. Free Radic Res 36:1323-1329
72. Reppert SM, Weaver DR (2002) Coordination of circadian timing in mammals. Nature 418:935-941
73. Rothman KJ (1976) Causes. Am J Epidemiol 104:587-592
74. Ruby NF, Brennan TJ, Xie X, Cao V, Franken P, Heller HC, O'Hara BF (2002) Role of melanopsin in circadian responses to light. Science 298:2211-2213
75. Sack RL, Lewy AJ, Erb DL, Vollmer WM, Singer CM (1986) Human melatonin production decreases with age. J Pineal Res 3:379-388
76. Sack RL, Lewy AJ, Blood ML, Keith LD, Nakagawa H (1992) Circadian rhythm abnormalities in totally blind people: incidence and clinical significance. J Clin Endocrinol Metab 75:127-134
77. Sanchez-Barcelo EJ, Cos S, Fernndez R, Mediavilla MD (2003) International congress on hormonal steroids and hormones and cancer: melatonin and mammary cancer: a short review. Endocr Relat Cancer 10:153-159
78. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA (2001) Rotating night shifts and risk of breast cancer in the Nurses' Health Study. J Natl Cancer Inst 93:1563-1568
79. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Fuchs CS, Colditz GA (2003) Night-shift work and risk of colorectal cancer in the Nurses' Health Study. J Natl Cancer Inst 95:825-828
80. Schroedinger E (1948) What is life? The physical aspects of the living cell. Cambridge University Press, Cambridge, pp 69, 75
81. Skene DJ, Swaab DF (2003) Melatonin rhythmicity: effect of age and Alzheimer's disease. Exp Gerontol 38:199-206
82. Skene DJ, Lockley SW, Arendt J (1999) Use of melatonin in the treatment of phase shift and sleep disorders. Adv Exp Med Biol 467:79-84
83. Soni BG, Foster RG (1997) A novel and ancient vertebrate opsin. FEBS Lett 406:279-283
84. Soni BG, Philp AR, Foster RG, Knox BE (1998) Novel retinal photoreceptors. Nature 394:27-28
85. Stevens RG (1987) Electric power use and breast cancer: a hypothesis. Am J Epidemiol 125:556-561
86. Stevens RG (2002) Lighting during the day and night: possible impact on risk of breast cancer. Neuroendocrinol Lett 23 Suppl 2:57-60
87. Stevens RG, Rea MS (2001) Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control 12:279-287
88. Stevens RG, Davis S, Thomas DB, Anderson LE, Wilson BW (1992) Electric power, pineal function, and the risk of breast cancer. FASEB J 6:853-860
89. Stokkan K-A, Reiter RJ (1994) Melatonin rhythms in Arctic urban residents. J Pineal Res 16:33-36
90. Tan DX, Poeggeler B, Reiter RJ, Chen LD, Manchester LC, Barlow-Walden LR (1993) The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett 70:65-71
91. Thapan K, Arendt J, Skene DJ (2001) An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol 535:261-267
92. Thresher RJ, Vitaterna MH, Miyamoto Y, Kazantsev A, Hsu DS, Petit C, Selby CP, Dawut L, Smithies O, Takahashi JS, Sancar A (1998) Role of mouse cryptochrome blue-light photoreceptor in circadian photoresponses. Science 282:1490-1494
93. Tynes T, Hannevik M, Andersen A, Vistnes AI, Haldorsen T (1996) Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 7:197-204
94. Verkasalo PK, Pukkala E, Stevens RG, Ojamo M, Rudanko S-L (1999) Inverse association between breast cancer incidence and degree of visual impairment in Finland. Br J Cancer 80:1459-1460
95. Vijayalaxmi, Thomas CR, Reiter RJ, Herman TS (2002) Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 20:2575-2601
96. Wartenberg D, Stapleton CP (1998) Risk of breast cancer is also increased among retired US female airline cabin attendants. BMJ 316:1902
97. Wetterberg L, Eberhard G, Knorring L von, Kohan MA, Ylipää E, Rutz W, Bratlid T, Lacoste V, Thompson C, Yoneda H, Rosenthal NE, McGuire M, Polleri A, Freedman M, Morton DJ, Redman J, Berigannaki JD, Shapiro C, Driver H, Yuwiler A (1993) The influence of age, sex, height, weight, urine volume and latitude on melatonin concentrations in urine from normal subjects: a multinational study. In: Wetterberg L (ed) Light and biological rhythms in man. Pergamon, Oxford, pp 275-286
98. Wetterberg L, Bratlid T, Knorring L von, Eberhard G, Yuwiler A (1999a) A multinational study of the relationships between nighttime urinary melatonin production, age, gender, body size, and latitude. Eur Arch Psychiatr Clin Neurosci 249:256-262
99. Wetterberg L, Bergiannaki JD, Paparrigopoulos T, Knorring L von, Eberhard G, Bratlid T, Yuwiler A (1999b) Normative melatonin excretion: a multinational study. Psychoneuroendocrinology 24:209-226
100. Weydahl A, Sothern RB, Wetterberg L (1998) Seasonal variations in melatonin may modulate glycemic response to exercise. Percept Mot Skills 86:1061-1062
101. Zeitzer JM, Ayas NT, Shea SA, Brown R, Czeisler CA (2000) Absence of detectable melatonin and preservation of cortisol and thyrotropin rhythms in tetraplegia. J Clin Endocrinol Metab 85:2189-2196
102. Zisapel N (2001) Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. CNS Drugs 15:311-328